March 17, 2016

Innovative Liver Tumor Clinic Unites Specialists, Patients In One Site

Fighting liver cancer, quality of life

16-DDI-160-LiverTumorClinic-CQD-650×450

Cleveland Clinic’s Liver Tumor Clinic is designed to provide leading-edge management and treatment of diverse and complex liver malignancies. Patients have access to a multidisciplinary team of specialists — hepatobiliary and transplant surgeons, hepatologists, oncologists, radiation oncologists, interventional radiologists and specialized nurse coordinators — in a one-stop clinic, eliminating multiple appointments with different physicians at various locations.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

An innovative model

Federico Aucejo, MD, heads the Liver Tumor Clinic, and says the innovative multidisciplinary model allows the elaboration of treatment strategies tailored to each individual patient. The model — based on comprehensive disease evaluations, liver malignancy care paths and Tumor Board consensus — allows delivery of cost/effective individualized therapies. Patients are evaluated and treatment is coordinated in a short timeframe: less than 30 days.

“Physicians review medical records, image studies and laboratory values of all patients who are evaluated through the clinic in one central location. The presence of diverse specialists allows interdisciplinary discussions maximizing the patients’ options,” Dr. Aucejo says. “The concept of articulating value-based multidisciplinary clinics, care paths and tumor boards is evolving, innovative and adapts to the changing physiognomy of healthcare.”

The number of patients diagnosed with liver cancer continues to rise due to a variety of reasons including inefficient cancer screening and surveillance programs and emerging uncontrolled risk factors, Dr. Aucejo says.

Program Highlights:

The Liver Tumor Clinic treats all types of liver cancers including:

Advertisement
  • Hepatocellular carcinoma
  • Cholangiocarcinoma
  • Liver metastasis from colorectal cancer
  • Liver metastasis from neuroendocrine tumors
  • Gallbladder cancer
  • Others

Treatment options include diverse surgical interventions, and locoregional and medical oncological therapies only offered by the most highly specialized centers in the nation:

  • Surgical treatments – Extensive liver resections, two-stage hepatectomy, associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure, ex-vivo hepatectomy, liver transplantation, minimally invasive liver surgery via laparoscopic and robotic technology
  • Locoregional treatments – Microwave ablation, cryoablation, electroporation (NanoKnife) and radiofrequency ablation
  • Transcatheter therapies – Radioembolization, chemoembolization
  • Medical oncology treatments – Diverse systemic chemotherapies, molecular targeted therapies, and clinical trials

An immeasurable value

Such a multidisciplinary approach is invaluable to patients with liver cancers, says Cleveland Clinic oncologist Bassam Estfan, MD.

“Having such a resource at our disposal is an extremely valuable tool for optimal care for the increasingly complex and challenging cases we see,” Dr. Estfan says. “Shared clinic visits allow the team to discuss care as viewed from different vantage points. The cumulative multispecialty expertise allows piecing together different aspects of treatment and management to form a comprehensive care plan that is unique to every patient.”

Innovative discoveries

Innovation and treatment discoveries are pivotal within the mission of Cleveland Clinic’s Liver Tumor Clinic. Some of these endeavors include:

Advertisement
  • 3-D printing of liver models and computer software to aid surgical treatments of complex liver malignancies
  • Tissue, serum and breath bio-repository for translational research
  • Liver malignancy mice Xenograft research platform to study liver tumors from individual patients fostering personalized medicine in the field of liver oncology

For questions, contact Dr. Aucejo at aucejof@ccf.org. Refer a patient by calling 855.REFER.123.

Related Articles

Cleveland Clinic physiatrist
March 22, 2024
The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Doctors working on MGUS screening study
March 18, 2024
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access

How antibody drug conjugates work
February 13, 2024
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

Ad